Clinical Trial Update: A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 study of atezolizumab in combination with epacadostat in previously treated non-small cell lung cancer and urothelial cancer; the trial status is termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Urothelial Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Epacadostat (epacadostat)

Snippet

Sponsor: Incyte Corporation | Conditions: NSCLC (Non-small Cell Lung Carcinoma), UC (Urothelial Cancer) | Phase 1 | Status: TERMINATED